Collaborations – University of Copenhagen

DanStem > About > Collaborations

Collaborations

With an aim to facilitate the exchange of scientific and organizational expertise and technology, DanStem has established and/or participates in several national and international partnerships and strategic collaborations. In addition, each research group also has a variety of international and national collaborations based on their specific research programs.  Our active international and national collaborations at the center level are shown below.

Strategic Partnership with the Helmholtz Zentrum München - German Research Center for Environmental Health (Munich, Germany) in translational diabetes research

The partnership aims to establish a strong R&D platform for manufacture of human pluripotent stem cell-derived pancreatic islet cells for future stem cell-based cell therapy in type 1 diabetes.


Scientific Partnership with the Department of Developmental and Stem Cell Biology at Institute Pasteur (Paris, France)

This partnership, to be inaugurated with a partnership meeting in spring 2019, aims to enhance scientific discussion, exchange and collaboration in basic stem cell and developmental biology.


EuroStemCell

The joint effort unites more than 90 European stem cell and regenerative medicine research labs to engage with the public about stem cell research and exchange ideas and train scientists in outreach related topics.  Scientists, clinicians, ethicists, social scientists and science communicators are all active participants.


Danish National Research Foundation Center for Stem Cell Decision Making, StemPhys

This DNRF-funded collaboration joins the forces of physics and stem cell biology with the goal of understanding and controlling stem cell commitment. StemPhys is located both at DanStem and the Niels Bohr Institute (Physics) at the Faculty of Science.


DanStem’s National Collaboration Initiative

The national collaboration initiative aims to strengthen and develop stem cell and developmental biology research in Denmark. With funding from the Novo Nordisk Foundation, DanStem provides support for projects that establish or extend national collaborations between DanStem and other Danish research environments outside of University of Copenhagen. Projects are reviewed and assessed by an international panel. The main selection criteria are scientific excellence, innovation, ambition, originality and contribution to the strengthening of stem cell and developmental biology research in Denmark. The national groups currently funded include:

2017 Torben Heick Jensen, Department of Molecular Biology and Genetics, University of Aarhus, and Kristian Helin, DanStem, University of Copenhagen

2017 Susanne Mandrup, Department of Biochemistry and Molecular Biology, University of Southern Denmark, and Bo Porse, DanStem, University of Copenhagen

2017 Ditte Caroline Andersen, Department of Clinical Biochemistry and Pharmacology, Laboratory of Molecular and Cellular Cardiology, Odense University Hospital/Clinical Institute, University of Southern Denmark, and Elke Ober, DanStem, University of Copenhagen

2017 Jonathan Brewer, Department of Biochemistry and Molecular Biology, University of Southern Denmark, and Jakub Sedzinski, DanStem, University of Copenhagen

2015 Torben Heick Jensen, Department of Molecular Biology and Genetics, University of Aarhus, and Kristian Helin, DanStem, University of Copenhagen

2015 Ditte Caroline Andersen, Department of Clinical Biochemistry and Pharmacology, Laboratory of Molecular and Cellular Cardiology, Odense University Hospital/Clinical Institute, University of Southern Denmark, and Elke Ober, DanStem, University of Copenhagen

2015 Susanne Mandrup, Department of Biochemistry and Molecular Biology, University of Southern Denmark, and Bo Porse, DanStem, University of Copenhagen

2012 Moustapha Kassem, University of Southern Denmark


Previously funded collaborative initiatives

HumEn EU HEALTH FP7 INNOVATION – Collaborative Project
This consortium aimed to upscale human insulin-producing beta cell production by efficient differentiation and expansion of endoderm progenitors.  Funding ended at the end of 2017.